Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cytokine Growth Factor Rev. 2014 Apr;25(2):83-9. doi: 10.1016/j.cytogfr.2014.02.001. Epub 2014 Feb 12.

Lymphotoxin and TNF: how it all began-a tribute to the travelers.

Author information

  • 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health 60 College St., New Haven, CT, 06510, USA. Electronic address: nancy.ruddle@yale.edu.

Abstract

The journey from the discoveries of lymphotoxin (LT) and tumor necrosis factor (TNF) to the present day age of cytokine inhibitors as therapeutics has been an exciting one with many participants and highs and lows; the saga is compared to that in "The Wizard of Oz". This communication summarizes the contributions of key players in the discovery of the cytokines and their receptors, the changes in nomenclature, and the discovery of the LT family's crucial role in secondary and tertiary lymphoid organs. The remarkable advances in therapeutics are detailed as are remaining problems. Finally, special tribute is paid to two pioneers in the field who have recently passed away: Byron H. Waksman and Lloyd Old.

Copyright © 2014 Elsevier Ltd. All rights reserved.

KEYWORDS:

Byron H. Waksman; Lloyd Old; Lymphotoxin; Secondary lymphoid organs; Tertiary lymphoid organs; The Wizard of Oz; Therapeutic inhibitors of LT and TNF; Tumor necrosis factor

PMID:
24636534
[PubMed - indexed for MEDLINE]
PMCID:
PMC4027955
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk